Moreover, KRAS-mutated NSCLC cells produce CCL5 [52], which plays an important role in antitumor immunity by promoting the recruitment of T cells and dendritic cells to the TME [53]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.